YPrime

eClinical technology company providing eCOA and IRT platforms for clinical trials.

YPrime, headquartered in Malvern, Pennsylvania, provides electronic clinical outcome assessment (eCOA) and interactive response technology (IRT/RTSM) platforms for clinical trials, competing with the established eCOA/IRT vendors. The company has been adding AI-assisted capabilities around study build and data review. As with any eCOA/IRT provider, per-study validation documentation and instrument licensing should be reviewed for regulated use.

Headquarters
Malvern, United States
Deployment options
cloud
Website
https://yprime.com
LinkedIn
https://www.linkedin.com/company/y-prime

Categories

AI Use Cases

  • Digital/Decentralized Trials

Vendor Scorecard

50% — Partial coverage. Coverage score — how completely Atlas documents YPrime across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.

Compliance & Validation — Not documented by Atlas

Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?

Deployment & Hosting — Documented

cloud

Pricing Transparency — Not documented by Atlas

Ask the vendor: What is your pricing model, and what drives total cost of ownership?

Implementation & Onboarding — Not documented by Atlas

Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?

Organization & Role Fit — Documented

Mid-Size Biotech, Large Pharma, CRO / CDMO, Clinical Operations, Data Management

Solution Scope — Documented

Clinical Data Management

Company Viability — Partially documented

Private

Always ask the vendor

Not captured in Atlas data — confirm directly. Excluded from the score above.

Data Rights & IP

Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?

Model Credibility & Explainability

Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?

Questions to Ask This Vendor

  • What does the study build timeline look like for our protocol complexity?
  • Which AI-assisted features are in production, and what do they automate?
  • What validation and compliance documentation is provided per study?
  • How is instrument licensing and translation handled for our endpoints?